A novel interplay between membrane and nuclear melatonin receptors in human lymphocytes: Significance in IL-2 production

Cellular and Molecular Life Sciences

Volumn 66, Issue 3, 2009, Pages 516-525

  Lardone, P J ^a   Carrillo Vico, A ^a   Molinero, P ^a   Rubio, A ^a   Guerrero, J M ^b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

cAMP; Melatonin; Melatonin receptors; MT1; RORalpha

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLIC AMP; FORSKOLIN; INTERLEUKIN 2; LUZINDOLE; MELATONIN RECEPTOR; PROSTAGLANDIN E2;

ADULT; ARTICLE; CELL FUNCTION; CYTOKINE PRODUCTION; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LEUKEMIA CELL LINE; LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMID; PROTEIN DEPLETION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA EXTRACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ADULT; ANIMALS; CELL MEMBRANE; CELL NUCLEUS; CYCLIC AMP; DINOPROSTONE; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTES; MELATONIN; MIDDLE AGED; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; TRANS-ACTIVATORS; TRYPTAMINES;

EID: 59349102293     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8601-5     Document Type: Article

References (41)

1. Markus, R. P., Ferreira, Z. S., Fernandes, P. A. and Cecon, E. (2007) The immune-pineal axis: a shuttle between endocrine and paracrine melatonin sources. Neuroimmunomodulation. 14, 126-133.
2. Tan, D. X., Manchester, L. C., Terron, M. P., Flores, L. J. and Reiter, R. J. (2007) One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J. Pineal Res. 42, 28-42.
3. Hoang, B. X., Shaw, D. G., Pham, P. T. and Levine, S. A. (2007) Neurobiological effects of melatonin as related to cancer. Eur. J. Cancer Prev. 16, 511-516.
4. Carrillo-Vico, A., Reiter, R. J., Lardone, P. J., Herrera, J. L., Fernandez-Montesinos, R., Guerrero, J. M. and Pozo, D. (2006) The modulatory role of melatonin on immune responsiveness. Curr. Opin. Investig. Drugs. 7, 423-431.
5. Reiter, R. J., Tan, D. X., Manchester, L. C., Pilar, T. M., Flores, L. J. and Koppisepi, S. (2007) Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv. Med. Sci. 52, 11-28.
6. Dubocovich, M. L. (2007) Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med. 8 Suppl 3, 34-42.
7. Becker-Andre, M., Wiesenberg, I., Schaeren-Wiemers, N., Andre, E., Missbach, M., Saurat, J. H. and Carlberg, C. (1994) Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 269, 28531-28534.
8. Garcia-Maurino, S., Gonzalez-Haba, M. G., Calvo, J. R., Rafii-El-Idrissi, M., Sanchez-Margalet, V., Goberna, R. and Guerrero, J. M. (1997) Melatonin enhances IL-2, IL-6, and IFNgamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J. Immunol. 159, 574-81.
9. Garcia-Maurino, S., Pozo, D., Carrillo-Vico, A., Calvo, J. R. and Guerrero, J. M. (1999) Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci. 65, 2143-50.
10. Carrillo-Vico, A., Guerrero, J. M., Lardone, P. J. and Reiter, R. J. (2005) A review of the multiple actions of melatonin on the immune system. Endocrine. 27, 189-200.
11. Kvetnoy, I., Sandvik, A. K. and Waldum, H. L. (1997) The diffuse neuroendocrine system and extrapineal melatonin. J. Mol. Endocrinol. 18, 1-3.
12. Kvetnoy, I. M., Ingel, I. E., Kvetnaia, T. V., Malinovskaya, N. K., Rapoport, S. I., Raikhlin, N. T., Trofimov, A. V. and Yuzhakov, V. V. (2002) Gastrointestinal melatonin: cellular identification and biological role. Neuro. Endocrinol. Lett. 23, 121-132.
13. Kvetnoy, I. M. (1999) Extrapineal melatonin: location and role within diffuse neuroendocrine system. Histochem. J. 31, 1-12.
14. Carrillo-Vico, A., Calvo, J. R., Abreu, P., Lardone, P. J., Garcia-Maurino, S., Reiter, R. J. and Guerrero, J. M. (2004) Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J. 18, 537-539.
15. Carrillo-Vico, A., Lardone, P. J., Fernandez-Santos, J. M., Martin-Lacave, I., Calvo, J. R., Karasek, M. and Guerrero, J. M. (2005) Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2/interleukin-2 receptor system. J. Clin. Endocrinol. Metab. 90, 992-1000.
16. Lardone, P. J., Carrillo-Vico, A., Naranjo, M. C., De, F. B., Vallejo, A., Karasek, M. and Guerrero, J. M. (2006) Melatonin synthesized by Jurkat human leukemic T cell line is implicated in IL-2 production. J. Cell Physiol. 206, 273-279.
17. Garcia-Maurino, S., Gonzalez-Haba, M. G., Calvo, J. R., Goberna, R. and Guerrero, J. M. (1998) Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production by human blood mononuclear cells. J. Neuroimmunol. 92, 76-84.
18. Garcia-Maurino, S., Pozo, D., Calvo, J. R. and Guerrero, J. M. (2000) Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J. Pineal Res. 29, 129-37.
19. Carrillo-Vico, A., Garcia-Maurino, S., Calvo, J. R. and Guerrero, J. M. (2003) Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor. FASEB J. 17, 755-757.
20. Boyum, A. (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab Invest Suppl. 97, 77-89.
21. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
22. Rappaport, R. S. and Dodge, G. R. (1982) Prostaglandin E inhibits the production of human interleukin 2. J. Exp. Med. 155, 943-948.
23. Garcia-Perganeda, A., Pozo, D., Guerrero, J. M. and Calvo, J. R. (1997) Signal transduction for melatonin in human lymphocytes: involvement of a pertussis toxin-sensitive G protein. J. Immunol. 159, 3774-3781.
24. Dubocovich, M. L., Yun, K., Al-Ghoul, W. M., Benloucif, S. and Masana, M. I. (1998) Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J. 12, 1211-1220.
25. Reppert, S. M., Godson, C., Mahle, C. D., Weaver, D. R., Slaugenhaupt, S. A. and Gusella, J. F. (1995) Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc. Natl. Acad. Sci. U. S. A. 92, 8734-8738.
26. Morgan, D. A., Ruscetti, F. W. and Gallo, R. (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 193, 1007-1008.
27. Akbar, A. N., Borthwick, N. J., Wickremasinghe, R. G., Panayoitidis, P., Pilling, D., Bofill, M., Krajewski, S., Reed, J. C. and Salmon, M. (1996) Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur. J. Immunol. 26, 294-299.
28. Turka, L. A. and Walsh, P. T. (2008) IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells. Front Biosci. 13, 1440-1446.
29. Anderton, S. M. and Liblau, R. S. (2008) Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system. Curr. Opin. Neurol. 21, 248-254.
30. Baratelli, F., Lin, Y., Zhu, L., Yang, S. C., Heuze-Vourc'h, N., Zeng, G., Reckamp, K., Dohadwala, M., Sharma, S. and Dubinett, S. M. (2005) Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J. Immunol. 175, 1483-1490.
31. Mahic, M., Yaqub, S., Johansson, C. C., Tasken, K. and Aandahl, E. M. (2006) FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J. Immunol. 177, 246-254.
32. Narumiya, S. (1994) Prostanoid receptors. Structure, function, and distribution. Ann. N. Y. Acad. Sci. 744, 126-138.
33. Guerrero, J. M., Pozo, D., Garcia-Maurino, S., Osuna, C., Molinero, P. and Calvo, J. R. (2000) Involvement of nuclear receptors in the enhanced IL-2 production by melatonin in Jurkat cells. Ann. N. Y. Acad. Sci. 917, 397-403.
34. Minakuchi, R., Wacholtz, M. C., Davis, L. S. and Lipsky, P. E. (1990) Delineation of the mechanism of inhibition of human T cell activation by PGE2. J. Immunol. 145, 2616-2625.
35. Power, R. F., Conneely, O. M. and O'Malley, B. W. (1992) New insights into activation of the steroid hormone receptor superfamily. Trends Pharmacol. Sci. 13, 318-323.
36. Masana, M. I. and Dubocovich, M. L. (2001) Melatonin receptor signaling: finding the path through the dark. Sci. STKE. 2001, E39-
37. Witt-Enderby, P. A., Bennett, J., Jarzynka, M. J., Firestine, S. and Melan, M. A. (2003) Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci. 72, 2183-2198.
38. Kane, C. D. and Means, A. R. (2000) Activation of orphan receptor-mediated transcription by Ca(2+)/calmodulin-dependent protein kinase IV. EMBO J. 19, 691-701.
39. Audinot, V., Bonnaud, A., Grandcolas, L., Rodriguez, M., Nagel, N., Galizzi, J. P., Balik, A., Messager, S., Hazlerigg, D. G., Barrett, P., Delagrange, P. and Boutin, J. A. (2008) Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors. Biochem. Pharmacol. 75, 2007-2019.
40. Dubocovich, M. L., Rivera-Bermudez, M. A., Gerdin, M. J. and Masana, M. I. (2003) Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci. 8, d1093-d1108.
41. Dai, J., Ram, P. T., Yuan, L., Spriggs, L. L. and Hill, S. M. (2001) Transcriptional repression of RORalpha activity in human breast cancer cells by melatonin. Mol. Cell Endocrinol. 176, 111-120.